MAS
IONS icon

MPWM Advisory Solutions’s Ionis Pharmaceuticals IONS Stock Holding History

MPWM Advisory Solutions’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-110
Closed -$4.35K – 531
2025
Q2 		$4.35K Hold
110
– – ﹤0.01% 372
2025
Q1 		$3.32K Buy
+110
New +$3.6K ﹤0.01% 410

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MPWM Advisory Solutions's IONS Position: Q3 2025 in Review

MPWM Advisory Solutions sold out of Ionis Pharmaceuticals (IONS) in Q3 2025, closing a stake of 110 shares — an estimated $4.35K sold.

MPWM Advisory Solutions first reported a position in IONS in Q1 2025 and held it in 2 quarters. The position peaked at $4.35K in Q2 2025. 435 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

  • MPWM Advisory Solutions reported no remaining Ionis Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • MPWM Advisory Solutions sold 110 Ionis Pharmaceuticals shares in Q3 2025, an estimated $4.35K.
  • MPWM Advisory Solutions first reported a position in Ionis Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • MPWM Advisory Solutions's Ionis Pharmaceuticals position peaked at $4.35K in Q2 2025.
  • 435 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on MPWM Advisory Solutions's 13F filing for Q3 2025, filed 14 Nov 2025.